Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ingersoll, J. Articles by Caliendo, A. M. Search for Related Content PubMed PubMed Citation Articles by Ingersoll, J. Articles by Caliendo, A. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2008, p. 1628-1630, Vol. 46, No. 5
0095-1137/08/$08.00+0     doi:10.1128/JCM.02486-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Stability of Trichomonas vaginalis DNA in Urine Specimens

Jessica Ingersoll,¹ Tameka Bythwood,¹ Deborah Abdul-Ali,¹ Gina M. Wingood,^2,3 Ralph J. Diclemente,^2,3 and Angela M. Caliendo^1,3*

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia,¹ Department of Behavioral Science, Rollins School of Public Health, Atlanta, Georgia,² Center for AIDS Research, Emory University, Atlanta, Georgia³

Received 28 December 2007/ Returned for modification 13 February 2008/ Accepted 3 March 2008

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Trichomonas vaginalis is an important pathogen in both men and women. Culture is considered the diagnostic gold standard, although studies have shown that PCR is more sensitive than either culture or wet mount for the diagnosis of T. vaginalis infections. We sought to identify a simple method for stabilizing T. vaginalis DNA in urine samples that could be easily applied to molecular testing. The stability of T. vaginalis DNA in 40 urine samples was assessed by storage for various times at either 4°C or room temperature with or without the Becton Dickinson urine preservative transport (UPT) kit. Overall, there was better stability of T. vaginalis DNA when specimens were stored at 4°C than when they were stored at 20 to 22°C and when the UPT system was used. T. vaginalis DNA was stable in specimens stored without using the UPT at 4°C for about 3 days and at room temperature for only 1 day. For specimens placed in the UPT within 24 h (times of 1, 6, and 24 h) of collection, the DNA was stable for up to 30 days when stored at 4°C. For specimens stored at room temperature, the urine should be added to the UPT ideally within 1 hour of collection, and in this case the DNA remained stable for up to 30 days. When storing specimens at room temperature, a delay of 24 h prior to adding to UPT led to an unacceptably high loss of assay sensitivity.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Trichomonas vaginalis is a common sexually transmitted disease, with an estimated 7.4 million new cases annually in the United States and as many as 180 million cases worldwide (13). T. vaginalis can cause symptoms in both men and women and can cause severe complications in pregnant women. Symptoms in women include vaginal discharge and vulval irritation; if untreated, more-severe complications may occur, including endometritis, cervical erosion, and infertility (3, 9). T. vaginalis infections in pregnant women can lead to premature rupture of membranes, low-birth-weight infants, and preterm deliveries (2). In men, infection with T. vaginalis may cause nongonococcal urethritis, with untreated infections causing chronic prostatitis, epididymitis, infertility, or urethral strictures (3, 9). Moreover, T. vaginalis infection can lead to an increased risk of acquiring human immunodeficiency virus type 1 infection due to the local inflammation caused by T. vaginalis infections in the genital tract (5, 7, 8, 11).

There are numerous reports supporting the role of PCR in the diagnosis of T. vaginalis infections from genital specimens; these reports have shown that the detection of T. vaginalis DNA by PCR is significantly more sensitive than both culture and wet mount examination (1, 4, 6, 12, 14, 15). We have previously reported that vaginal swabs collected with the BDProbeTec dry swab system were a reliable specimen for PCR testing and allowed the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and T. vaginalis from a single specimen (1). For clinical studies using urine specimens, our procedure for stabilizing T. vaginalis was cumbersome and involved adding an aliquot of urine to Fuji medium (Remel, Lenexa, KS), to prevent autolysing of the T. vaginalis organisms. In this report, we describe a simple method for stabilizing T. vaginalis DNA in urine samples by use of the Becton Dickinson urine preservative transport (UPT) kit, which is routinely used for Chlamydia trachomatis and Neisseria gonorrhoeae testing in clinical laboratories. The use of UPT for T. vaginalis testing would be easy for clinics and laboratories and would still allow testing for C. trachomatis, N. gonorrhoeae, and T. vaginalis DNA from a single specimen.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Samples. Urine samples were collected from 40 volunteers following an institutional review board-approved protocol (#IRB00001614). Fifty to 100 ml of first-voided urine was collected from each volunteer in a sterile cup. An aliquot of each sample was tested for the presence of T. vaginalis DNA by use of a real-time PCR assay (1). All samples tested negative for T. vaginalis DNA. The urine specimens were then spiked with T. vaginalis organisms. For this purpose, T. vaginalis was cultured using the InPouch TV system (BioMed Diagnostics, San Jose, CA) in the clinical microbiology laboratory. An aliquot of this suspension was used to spike each of the 40 urine samples. The goal was to create specimens with a low to moderate concentration of T. vaginalis DNA; the amount of suspension used to spike the urine samples was estimated to give a positive signal with a cycle threshold (C_T) value of 30 to 35. This range of C_T values was chosen based on clinical experience with the assay; culture-negative PCR-positive specimens tend to have a higher C_T value, indicating a lower concentration of DNA in the sample. This high range of C_T values is near the limit of detection of the assay and should allow the detection of subtle changes in DNA degradation.

Trichomonas vaginalis real-time PCR assay. Urine samples were processed either directly or with the BD UPT kit (Becton Dickinson, Sparks, MD) (see below for details of study design). The UPT tubes contain 50 µl of a <742.5 mM solution of potassium-EDTA. For samples processed with the UPT, 3 ml of urine was added to the UPT and, after storage for the designated period of time, the specimen was processed following the manufacturer's recommendations. Briefly, the sample was heated to 114°C for 10 min, cooled for 15 min, and centrifuged at 3,000 x g for 30 min. The pellet was resuspended in 1.5 ml of the Becton Dickinson dimethyl sulfoxide buffer. A 5-µl aliquot was used for PCR testing. For samples processed without the UPT, 3 ml of urine was heated directly and the above-described procedure was followed. The T. vaginalis real-time PCR assay was performed as previously described (1).

Study design. The study was designed to determine how long the T. vaginalis DNA would remain stable at 4°C or room temperature before it was added to the UPT and then to determine how long the DNA was stable once in the UPT (Table 1). There were four arms to the study, with each containing 10 different urine samples. An aliquot of each urine sample was processed within 5 min of spiking with T. vaginalis and served as the time zero specimen. For arm 1, each of the 10 urine samples was stored at 4°C and an aliquot of each was added to UPT 1 h, 6 h, and 24 h after spiking; once in the UPT, an aliquot was processed 1 day, 3 days, 7 days, and 30 days later. For arm 2, each of the 10 urine samples was stored at room temperature (20 to 22°C) and an aliquot of each was added to UPT 1 h, 6 h, and 24 h after spiking; once in the UPT, an aliquot was processed 1 day, 3 days, 7 days, and 30 days later. For arm 3, the 10 urine samples were stored at 4°C without UPT and an aliquot was processed 1 day, 3 days, 7 days, and 30 days later. For arm 4, the 10 urine samples were stored at room temperature (20 to 22°C) without UPT and an aliquot was processed 1 day, 3 days, 7 days, and 30 days later. All specimens from a given time point were processed together and tested in the same run. All runs included positive and negative controls; the positive control C_T values fell within a range of 30.6 to 31.7.

View this table: [in this window] [in a new window]

TABLE 1. Study designa

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Thirty-eight of the time zero specimens tested positive for T. vaginalis DNA, with C_T values ranging from 30.8 to 39.3. Two of the samples were undetectable at time zero but were detectable at subsequent time points. This likely relates to sampling error in our goal to create specimens with a low amount of DNA.

The results of the four arms were initially analyzed based on the qualitative result of positive or negative results of tests for T. vaginalis DNA. In comparing arms 3 and 4 (Table 2), storage at room temperature without the use of UPT led to a high number of aliquots negative for T. vaginalis DNA compared to storage at 4°C; the dropout of positive results increased with longer storage time. When stored at 4°C, only 1 of the 40 aliquots was negative at the four time points tested; however, when stored at 20 to 22°C, a total of 10 of the 40 aliquots were negative. For arms 1 and 2, with the use of UPT, all aliquots remained positive even with delays of up to 24 h prior to putting samples into UPT and after storing in the UPT for up to 30 days.

View this table: [in this window] [in a new window]

TABLE 2. Results for urine samples stored at 4°C or room temperature without addition to the UPT

The C_T values obtained from the PCR testing were also analyzed, as this provides a semiquantitative measure of the amount of DNA in the sample. For arm 1 (Table 3), under the various storage conditions, the rise in C_T for the aliquots ranged from 0 to 1.5 cycles, and there was no consistent increase in C_T for aliquots that were maintained for up to 24 h at 4°C prior to placing the sample in UPT. Moreover, once in UPT, the DNA remained stable for up to 30 days. For storage at 20 to 22°C (arm 2) (Table 4), there was a consistent increase in the C_T values for aliquots held for 24 h prior to the addition of the sample to the UPT; a similar but less pronounced effect was seen for samples maintained at room temperature for 6 h prior to the addition of UPT. A drop off in sensitivity of 1 log₁₀ (3.3 cycles) was seen for three different time points when aliquots were stored with UPT at 20 to 22°C, compared to none for samples held at 4°C. For specimens stored without the use of UPT (arms 3 and 4) (Table 5), there was a 0.6-cycle increase in C_T for aliquots held for 1 and 3 days at 4°C; this increased to 3.6 and 2.3 cycles for aliquots held 7 and 30 days, respectively. An even more pronounced increase in C_T value was seen for specimens stored at room temperature without the use of UPT, with the most dramatic increases being observed at 7 and 30 days. The rise in C_T value observed for aliquots held 7 and 30 days at room temperature would correlate with a drop in sensitivity of 1.9 to 2.0 log₁₀.

View this table: [in this window] [in a new window]

TABLE 3. Results for arm 1 (4°C)

View this table: [in this window] [in a new window]

TABLE 4. Results for arm 2 (20 to 22°C)

View this table: [in this window] [in a new window]

TABLE 5. Results for arms 3 and 4

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
T. vaginalis remains an important pathogen in both men and women. Traditionally, the diagnosis has been made by either wet mount or culture. However, several recent reports have shown that the detection of T. vaginalis DNA by PCR is more sensitive than either culture or wet mount (1, 4, 6, 12, 14, 15). Despite the superior performance of PCR, few laboratories have adopted molecular testing for the routine detection of T. vaginalis infections. The ability to use the same specimen, transport device, and nucleic acid extraction method that is used for C. trachomatis and N. gonorrhoeae testing would be helpful to laboratories considering implementing T. vaginalis PCR testing. We have previously described the use of the BD swab system as an appropriate collection device for T. vaginalis PCR testing (1). This report describes the stability of T. vaginalis DNA in urine stored at both 4°C and room temperature, with and without the use of UPT.

Overall, there was better stability of T. vaginalis DNA when urine specimens were stored at 4°C than when they were stored at 20 to 22°C and when the UPT system was used. Based on qualitative results (positive or negative for T. vaginalis DNA), it appeared that T. vaginalis DNA in urine was stable at 4°C for 30 days without the use of UPT, as 39 of the 40 aliquots remained positive over that time period. However, when assessing the rise in C_T value when specimens were stored at 4°C, it appears that there was a loss of sensitivity of the PCR assay when aliquots were held for more than 3 days without the use of UPT, with a rise in the mean C_T value of 2.3 to 3.6 cycles. For specimens stored at room temperature without the use of UPT, the rise in C_T value for urine aliquots held for more than 3 days was even more pronounced, at 4.4 to 4.6 cycles. To better assess what rise in C_T value was important, we reviewed data from our previously published study (1), in which urine samples were collected from women and tested for T. vaginalis DNA. A total of 52 specimens were positive for T. vaginalis DNA. The mean C_T observed for specimens that were both PCR and culture positive for T. vaginalis was 26.2, with a range of 18.3 to 39.1, while specimens that were culture negative and PCR positive had a mean C_T value of 33.7, with a range of 23.7 to 39.8 (1). In that study, there were no data available on whether the women were asymptomatic or symptomatic. Seven of the 52 (13.5%) positive specimens had a C_T value of >36. Based on these data, a significant number of clinical specimens would be expected to have a high C_T value, so a rise in C_T value of greater than 2 cycles may lead to a loss in clinical sensitivity. Using this 2-cycle rise in C_T value as a general guide, T. vaginalis DNA in urine was stable when stored without UPT at 4°C for about 3 days and at room temperature for only 1 day. For specimens placed in UPT within 24 h (times of 1, 6, and 24 h) of collection, the DNA was stable for up to 30 days when stored at 4°C. For specimens stored at room temperature, ideally the urine should be added to the UPT within 1 hour of collection, which can be done at the site of collection. DNA then remained stable for up to 30 days. When storing specimens at room temperature, a delay of 24 h prior to adding the aliquot to UPT led to an unacceptably high loss of assay sensitivity.

Shafir et al. (10) recently studied the effect of processing time delay on culture and PCR testing for T. vaginalis. Samples were held for various times at either room temperature or 37°C. The sensitivity of culture dropped off dramatically after 30 min for samples held at either 37°C or room temperature. For PCR testing, the sensitivity of the test began to drop off after 60 min of storage at either 37°C or room temperature. Our results were similar in that the sensitivity of PCR testing began to drop off after 1 day of storage at room temperature without the use of UPT.

In summary, the use of the UPT is an effective method to stabilize T. vaginalis DNA in urine for PCR testing. Ideally, urine should be added to the UPT within 1 hour of collection or stored at 4°C for up to 3 days before adding the urine to the UPT. Under these conditions, once in the UPT, the DNA is stable for up to 30 days. The use of the UPT allows laboratories to easily test for C. trachomatis, N. gonorrhoeae, and T. vaginalis DNA from a single specimen.

 
This work was supported in part by the Emory Center for AIDS Research (P30 AI050409).

 
* Corresponding author. Mailing address: Emory University Hospital, Clinical Labs, H180, 1364 Clifton Road, Atlanta, GA 30322. Phone: (404) 721-5721. Fax: (404) 727-3133. E-mail: acalien{at}emory.edu

Published ahead of print on 12 March 2008.

Top ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 

1
1. Caliendo, A. M., J. A. Jordan, A. M. Green, J. Ingersoll, R. J. Diclemente, and G. M. Wingood. 2005. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol. 13:145-150.[CrossRef][Medline]
2
2. Cotch, M. F., J. G. Pastorek II, R. P. Nugent, S. L. Hillier, R. S. Gibbs, D. H. Martin, D. A. Eschenbach, R. Edelman, J. C. Carey, J. A. Regan, M. A. Krohn, M. A. Klebanoff, A. V. Rao, G. G. Rhoads, et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360.[Medline]
3
3. Graves, A., and W. A. Gardner, Jr. 1993. Pathogenicity of Trichomonas vaginalis. Clin. Obstet. Gynecol. 36:145-152.[CrossRef][Medline]
4
4. Jordan, J. A., D. Lowery, and M. Trucco. 2001. TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens. J. Clin. Microbiol. 39:3819-3822.[Abstract/Free Full Text]
5
5. Laga, M., A. Manoka, M. Kivuvu, B. Malele, M. Tuliza, N. Nzila, J. Goeman, F. Behets, V. Batter, M. Alary, et al. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102.[Medline]
6
6. Madico, G., T. C. Quinn, A. Rompalo, K. T. McKee, Jr., and C. A. Gaydos. 1998. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J. Clin. Microbiol. 36:3205-3210.[Abstract/Free Full Text]
7
7. Moodley, P., C. Connolly, and A. W. Sturm. 2002. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 185:69-73.[CrossRef][Medline]
8
8. Rendon-Maldonado, J., M. Espinosa-Cantellano, C. Soler, J. V. Torres, and A. Martinez-Palomo. 2003. Trichomonas vaginalis: in vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes. J. Eukaryot. Microbiol. 50:43-48.[CrossRef][Medline]
9
9. Schwebke, J. R. 2002. Update of trichomoniasis. Sex. Transm. Infect. 78:378-379.[Abstract/Free Full Text]
10
10. Shafir, S. C., and F. J. Sorvillo. 2006. Viability of Trichomonas vaginalis in urine: epidemiologic and clinical implications. J. Clin. Microbiol. 44:3787-3789.[Abstract/Free Full Text]
11
11. Sorvillo, F., and P. Kerndt. 1998. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351:213-214.[Medline]
12
12. van Der Schee, C., A. van Belkum, L. Zwijgers, E. van Der Brugge, L. O'Neill, E. A. Luijendijk, T. van Rijsoort-Vos, W. I. van Der Meijden, H. Verbrugh, and H. J. Sluiters. 1999. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J. Clin. Microbiol. 37:4127-4130.[Abstract/Free Full Text]
13
13. Weinstock, H., S. Berman, and W. Cates, Jr. 2004. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sex. Reprod. Health 36:6-10.[CrossRef][Medline]
14
14. Wendel, K. A., E. J. Erbelding, C. A. Gaydos, and A. M. Rompalo. 2002. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin. Infect. Dis. 35:576-580.[CrossRef][Medline]
15
15. Wiesenfeld, H. C., D. L. Lowry, R. P. Heine, M. A. Krohn, H. Bittner, K. Kellinger, M. Shultz, and R. L. Sweet. 2001. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex. Transm. Dis. 28:321-325.[CrossRef][Medline]

---

Journal of Clinical Microbiology, May 2008, p. 1628-1630, Vol. 46, No. 5
0095-1137/08/$08.00+0     doi:10.1128/JCM.02486-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Shafir, S. C., Sorvillo, F. J., Smith, L. (2009). Current Issues and Considerations Regarding Trichomoniasis and Human Immunodeficiency Virus in African-Americans. Clin. Microbiol. Rev. 22: 37-45 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ingersoll, J. Articles by Caliendo, A. M. Search for Related Content PubMed PubMed Citation Articles by Ingersoll, J. Articles by Caliendo, A. M.